BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22056812)

  • 1. Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1).
    Li P; Du Q; Cao Z; Guo Z; Evankovich J; Yan W; Chang Y; Shao L; Stolz DB; Tsung A; Geller DA
    Cancer Lett; 2012 Jan; 314(2):213-22. PubMed ID: 22056812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma.
    Hu M; Huang H; Zhao R; Li P; Li M; Miao H; Chen N; Chen M
    Oncol Rep; 2014 Feb; 31(2):649-56. PubMed ID: 24297300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
    Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
    Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
    Wang Y; Han C; Lu L; Magliato S; Wu T
    Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.
    Yin L; Fang Z; Shen NJ; Qiu YH; Li AJ; Zhang YJ
    Drug Des Devel Ther; 2017; 11():2841-2850. PubMed ID: 29033545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.
    Chen YJ; Chi CW; Su WC; Huang HL
    Oncotarget; 2014 Jul; 5(13):4845-54. PubMed ID: 24947784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells.
    Li Y; Zhu H; Zeng X; Fan J; Qian X; Wang S; Wang Z; Sun Y; Wang X; Wang W; Ju D
    Mol Neurobiol; 2013 Jun; 47(3):1000-10. PubMed ID: 23329343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway.
    Shui L; Wang W; Xie M; Ye B; Li X; Liu Y; Zheng M
    Aging (Albany NY); 2020 Nov; 12(23):24318-24332. PubMed ID: 33260158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine enhances anti-proliferative effect of interferon-gamma against hepatocellular carcinoma cells.
    Okada T; Sawada T; Kubota K
    Cancer Lett; 2007 Apr; 248(1):24-31. PubMed ID: 16837131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
    Wei PL; Huang CY; Chang YJ
    PLoS One; 2019; 14(1):e0210513. PubMed ID: 30653551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-chalcone induces death by autophagy mediated by p53 up-regulation and β-catenin down-regulation on human hepatocellular carcinoma HuH7.5 cell line.
    Siqueira EDS; Concato VM; Tomiotto-Pellissier F; Silva TF; Bortoleti BTDS; Gonçalves MD; Costa IN; Junior WAV; Pavanelli WR; Panis C; Mantovani MS; Miranda-Sapla MM; Conchon-Costa I
    Phytomedicine; 2021 Jan; 80():153373. PubMed ID: 33096451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-directional roles of IRF-1 on autophagy diminish its prognostic value as compared with Ki67 in liver transplantation for hepatocellular carcinoma.
    Zhang HM; Li SP; Yu Y; Wang Z; He JD; Xu YJ; Zhang RX; Zhang JJ; Zhu ZJ; Shen ZY
    Oncotarget; 2016 Jun; 7(25):37979-37992. PubMed ID: 27191889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.
    Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY
    BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
    Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
    J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant potential of H22 hepatocarcinoma cells increases after recovery from IFN-γ-mediated inhibition.
    Gong W; Ma KZ; Liang X; Liu Y; Zhou Q; Zhang J; Chen H; Liu WW
    Cell Biol Int; 2011 Jul; 35(7):747-54. PubMed ID: 21261597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
    Zhang B; Yin X; Sui S
    Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.